Human Upper Extremity Allotransplantation: F/U Protocol

Description

Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.

Conditions

Amputation, Traumatic, Wounds and Injury, Hand Injuries

Study Overview

Study Details

Study overview

Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.

Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol

Human Upper Extremity Allotransplantation: F/U Protocol

Condition
Amputation, Traumatic
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 21287

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
  • * Completes the protocol informed consent form.
  • * Consents to sample collection and storage (biopsies).
  • * USA citizen or equivalent.
  • * Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.
  • * Candidate has not received an upper extremity allotransplant.
  • * Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Johns Hopkins University,

Jaimie Shores, M.D., PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

2036-07